Banggos, Zaldi E.
HRN: 22 25 97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CEFUROXIME 1.5GM (VIAL)
11/30/2022
12/07/2022
INTRAVENOUS
1.5 Grams
Q8h
Multiple Lacerated Wounds
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes